Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications
2017
Proton pump inhibitors alter the composition of the gut microbiota
2015
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era
2015
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
2017
Targeting Intestinal Inflammation With CD98 siRNA/PEI–loaded Nanoparticles
2013
The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?
2009
Intestinal strongyloidiasis and hyperinfection syndrome
2006
Serum Procalcitonin Levels in Patients with Primary Pulmonary Coccidioidomycosis
2014
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
2011
Cytokines in inflammatory bowel disease
2014 Standout
Non-traditional Antibacterial Therapeutic Options and Challenges
2019
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
American College of Gastroenterology Guideline: Management of Acute Pancreatitis
2013 Standout
Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data
2016
Ulcerative Colitis
2011 Standout
Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD‐subgroup analyses across four randomized trials
2009
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
2014 StandoutNature
Adalimumab safety in global clinical trials of patients with Crohnʼs disease
2009
Foundation models for generalist medical artificial intelligence
2023 StandoutNature
Further data supporting that paclitaxel‐associated acute pain syndrome is associated with development of peripheral neuropathy
2012
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Guidelines for the management of inflammatory bowel disease in adults
2011
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
2017 Standout
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Antibiotic development — economic, regulatory and societal challenges
2019 Standout
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Emerging Trends in “Smart Probiotics”: Functional Consideration for the Development of Novel Health and Industrial Applications
2017
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics
2010
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
2013
Optimizing the safety of biologic therapy for IBD
2010
Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection
2013
Coccidioidomycosis in liver transplantation
2005
Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
2012
Reshaping the gut microbiota: Impact of low calorie sweeteners and the link to insulin resistance?
2016
Daily Disinfection of High-Touch Surfaces in Isolation Rooms to Reduce Contamination of Healthcare Workers' Hands
2012
Therapeutic Potential of Fecal Microbiota Transplantation
2013
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Ulcerative colitis
2012 Standout
Multimodal biomedical AI
2022 Standout
Asymptomatic Clostridium difficile Colonisation and Onward Transmission
2013
Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
2009
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Crohn's disease
2016 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Colonization With Toxinogenic C. difficile Upon Hospital Admission, and Risk of Infection: A Systematic Review and Meta-Analysis
2015
Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges
2015
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
2013
Role of the gut microbiota in nutrition and health
2018 Standout
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
Ulcerative colitis
2016 Standout
Antibiotic resistance in the environment
2021 Standout
Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis
2012
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
2009
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study
2013
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Coccidioidal Meningitis
2010
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
A paradigm for the evaluation and management of spinal coccidioidomycosis
2015
Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis
2011
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
2011
Effectiveness of Screening Hospital Admissions to Detect Asymptomatic Carriers of Clostridium difficile: A Modeling Evaluation
2014
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel disease
2009
More Cleaning, Less Screening: Evaluation of the Time Required for Monitoring versus Performing Environmental Cleaning
2013
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
Mortality for Liver Disease in Patients With HIV Infection: A Cohort Study
2000
Hepatosplenic T cell lymphoma in inflammatory bowel disease: Table 1
2008
The pros, cons, and many unknowns of probiotics
2019 Standout
The human skin microbiome
2018 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care Patients
2010
Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update
2014
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
Inflammatory Bowel Disease: Mechanisms, Redox Considerations, and Therapeutic Targets
2013
Gut Microbiota in Health and Disease
2010 Standout
Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
2015
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
2009
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Fecal Microbiota Transplant
2015
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Eubiosis and dysbiosis: the two sides of the microbiota.
2016
Controlling Hospital-Acquired Infection: Focus on the Role of the Environment and New Technologies for Decontamination
2014
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Coccidioidomycosis
2005
Omadacycline: A New Tetracycline Antibiotic
2018
Strongyloides stercoralisin the Immunocompromised Population
2004 Standout
The Use of Infliximab for Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis
2008
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis
2010
The Public Health Impact of Coccidioidomycosis in Arizona and California
2011
Omadacycline for Community-Acquired Bacterial Pneumonia
2019
Microbiota transplantation restores normal fecal bile acid composition in recurrentClostridium difficileinfection
2013
Recent Advances in Our Understanding of the Environmental, Epidemiological, Immunological, and Clinical Dimensions of Coccidioidomycosis
2013
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
2011
Works of Robert Orenstein being referenced
HIV treatment-associated hepatitis.
1999
Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
2014
Safety and Durability of RBX2660 (Microbiota Suspension) for RecurrentClostridium difficileInfection: Results of the PUNCH CD Study
2015
A Targeted Strategy to Wipe Out Clostridium difficile
2011
Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
2008
Successful Treatment of Disseminated Nonmeningeal Coccidioidomycosis with Voriconazole
2004
An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study
2009
Asymptomatic Clostridium difficile colonization in a tertiary care hospital: Admission prevalence and risk factors
2013
A Randomized, Double Blind, Placebo‐Controlled Trial of an Oral Synbiotic (AKSB) for Prevention of Travelers' Diarrhea
2013
The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study
2011
Bacterial Complications of Strongyloidiasis: Streptococcus bovis Meningitis
1999
Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis
2017
Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19
2021
Successful colonoscopic fecal transplant for severe acute Clostridium difficile pseudomembranous colitis.
2014
Antibiotics and pancreatitis.
1997
Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
2018
Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis
2014